CIK 0001175680 · Non-accelerated filer<br>Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753056237
- Phone
- 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- 8-K Event New debt or obligation · Unregistered share sale
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event New debt or obligation · Unregistered share sale · Executive or director change · Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- S-3 Offering Registration Statement
- 8-K Event Unregistered share sale · Other events
- 15-12G Other 15-12G
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- SC 13D Stake Beneficial Ownership Report
- 8-K Event Material agreement · Unregistered share sale
- 4 Grant or award Chief Medical Officer acquired 21,124,440 shares (grant or award)
- S-8 POS Other Post-effective Amendment
Page 34 of 71 · 1,401 filings